Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live

Jefferies & UBS

16 shared events · Importance 7 · Last updated Aug 11, 2026

Importance
7
Shared Events
16
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
70
Business
Jefferies: Jefferies is acting as a joint book-running manager for the public offering by IDEAYA Biosciences, assisting in the sale of securities.
UBS: UBS is acting as a joint book-running manager for the public offering by IDEAYA Biosciences, supporting the securities transaction.
Jun 08, 2026 · 9 articles
70
Business
Jefferies: Jefferies is acting as a joint book-running manager for the public offering by Altor BioScience, facilitating the sale of shares and earning underwriting fees.
UBS: UBS is acting as a joint book-running manager for the public offering by Altor BioScience, facilitating the sale of shares and earning underwriting fees.
Jun 03, 2026 · 12 articles
65
Business
Jefferies: Jefferies is acting as a lead joint book-running manager for the proposed offering, playing a key role in facilitating the IPO.
UBS: UBS Investment Bank is acting as a joint book-running manager for the proposed offering.
Jul 02, 2026 · 6 articles
45
Regulatory
Jefferies: Jefferies is the primary subject of the investigation and has suffered significant stock price declines and a $30 million loss due to its exposure to First Brands.
UBS: UBS was mentioned in a Wall Street Journal article as also affected by First Brands' bankruptcy, but no specific impact on UBS is detailed.
Jul 07, 2026 · 6 articles
39
Business
Jefferies: Jefferies is a global coordinator and joint bookrunner, benefiting from the large IPO.
UBS: UBS Investment Bank is a joint bookrunner, earning underwriting fees.
Jul 20, 2026 · 6 articles
32
Business
Jefferies: Jefferies acted as an active book-running manager for Quantinuum's IPO, contributing to the successful execution of the offering.
UBS: UBS acted as a joint-book running manager for Quantinuum's IPO.
May 26, 2026 · 76 articles
30
Business
Jefferies: Jefferies is hosting one of the global healthcare conferences where Alvogen will present, providing a platform for investor engagement.
UBS: UBS is hosting a Virtual Generics and Biosimilars Day, where Alvogen will participate in a fireside chat.
Jun 02, 2026 · 6 articles
20
Business
Jefferies: Jefferies downgraded Datadog from Buy to Hold but raised price target to $280, citing valuation concerns after significant share price gains.
UBS: UBS raised its price target to $315, driven by anticipated growth in AI and insights from customer discussions.
Jul 17, 2026 · 7 articles
20
Business
Jefferies: Jefferies India is a book-running lead manager for the IPO.
UBS: UBS Securities India is a book-running lead manager for the IPO.
Jul 24, 2026 · 49 articles
20
Business
Jefferies: Jefferies raised its price target on Snowflake, indicating a positive outlook.
UBS: UBS reiterated a Buy rating on Snowflake, citing its AI revenue model.
Jul 29, 2026 · 6 articles
17
unfocused
Jefferies: Raj Kumar Goyal, chief European economist at Jefferies, commented on the market's need for an agreement to reopen the Strait of Hormuz.
UBS: UBS increased its price target on Micron Technology, contributing to Micron's stock surge and market valuation.
May 19, 2026 · 199 articles
14
International
Jefferies: Jefferies provides market commentary, but is not directly affected.
UBS: Bank providing analysis on oil prices. Informational role.
Apr 08, 2026 · 416 articles
10
Business
Jefferies: Acted as a lead arranger for debt financing.
UBS: Acted as a lead arranger for debt financing.
Aug 03, 2026 · 12 articles
10
Business
Jefferies: Jefferies downgraded Datadog from Buy to Hold but raised its price target to $280, expressing valuation concerns.
UBS: UBS raised its price target to $315 with a 'buy' rating, citing AI growth optimism.
Jul 28, 2026 · 6 articles
5
Business
Jefferies: Latimer previously established Jefferies' Canadian investment banking practice; no direct impact.
UBS: Latimer previously worked at UBS Securities Canada; no direct impact.
Jul 08, 2026 · 6 articles
0
Business
Apr 27, 2026 · 7 articles
ERGEN INTELLIGENCE
Explore this relationship live

Track how Jefferies and UBS interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.